Elephas Biosciences Corporation is partnering with the University of Louisville on a new research opportunity that will evaluate the impact of a combination therapy of surgical intervention and immunotherapy in…

Elephas Biosciences Corporation raised $40 million in a Series B-2 fundraising round, the company announced today. According to a release, the round included participation from existing investors including Northpond Ventures,…

Elephas Biosciences announced today that its first cancer patient was screened at inDNA Life Sciences in India, as part of a study that aims to demonstrate that the Elphas Live…

Elephas will collaborate with the Mayo Clinic Comprehensive Cancer Center to develop of oncology imaging diagnostics platform that will predict response to immunotherapy, the company announced today. “We are excited…

Elephas has closed a $55 million Series C funding round led by Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB), the company announced today. “We remain intensely…

Elephas Biosciences Corporation, a biotech company that developed an oncology diagnostics platform to predict response to immunotherapy, has raised $41.5 million in a Series B funding round, the company announced…